Telepatia AI raises $33M Series A led by a16z for AI "second brain" platform targeting Latin American physicians

Telepatia AI, a São Paulo-based healthtech founded by Colombian entrepreneur Nicolás Abad, has closed a $33M Series A led by Andreessen Horowitz (a16z), bringing total capital raised to $42M since the company's founding last year. Abad built the platform after his father — a physician himself — died from a preventable drug interaction, a personal loss that shaped both the product vision and its go-to-market in an underserved region.

The platform functions as an AI co-pilot for doctors, nurses, and hospitals across Latin America: it transcribes consultations in real time, auto-generates medical records, suggests diagnoses, treatments, and tests, and flags potential clinical inconsistencies — with final decisions always left to the clinician. Telepatia ships three distinct products (AI Doctor, AI Nurse, AI Auditor) integrated directly into hospital information systems and electronic health records.

Adoption metrics are notable: physicians reportedly use the platform an average of eight hours per day, institutional retention exceeds 90%, protocol adherence jumped from 84% to 99%, and clinicians save an average of 1.7 hours daily. The company says it now operates across more than 20 hospital systems in Latin America and reaches over 14 million patients, with Brazilian hospital network Mater Dei among its clients.

The round attracted a marquee angel roster alongside a16z: Palantir CTO Shyam Sankar, Nubank founder David Vélez, Rappi founder Simón Borrero, and members of Mexico's Slim family. More than 70% of the fresh capital will be deployed in Brazil — primarily into engineering, product, and commercial expansion — while the company eyes growth in Mexico, Chile, and Argentina. Brazil currently accounts for roughly half of revenue.